Patients & caregivers - Bristol Myers Squibb

We believe in the power of science in addressing some of the most challenging diseases of our time. We have a long history of developing life-saving medicines and a promising pipeline that will shape the next generation of treatment options for various multiple indications in four therapeutic areas.

Oncology

Our cancer research aims to develop medicines that offer patients better, healthier lives and make a recovery possible. Through years of focus, we have revolutionised the treatment of more than ten types of cancer.

Hematology

The focus of the company lies on myeloma, lymphoma, leukemia and myeloid diseases (such as myelodysplastic syndrome, beta-thalassemia and myeloproliferative neoplasms).

Immunology

We are committed every day to further research into autoimmune diseases to develop therapies that improve patients' lives. We are developing medicines for diseases such as psoriasis, inflammatory bowel disease, and multiple sclerosis.

Cardiovascular diseases

Our research into cardiovascular diseases began more than 60 years ago. Today, we continue our research to meet the needs of patients with severe cardiovascular diseases such as arterial thrombosis, certain types of heart failure, and cardiomyopathy.

Our responsibility >

As a socially responsible company, we strive to actively improve the health of the communities in which we live and work. Around the world, we are promoting health equality and are trying to improve the health outcomes of populations that are disproportionately affected by serious diseases.

Our medicines >

Our mission is to research, develop, and make available innovative medicines to patients with serious diseases.

Do you have a question?

Do you have a question? We are happy to help, so please do get in touch. For questions regarding adverse reactions in patients, please contact us via:

medicalinfo.belgium@bms.com